AstraZeneca Income Statement
View: Annual
This data is provided as per license from EDGAR Online
| Jun 07+ | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | -- | 29,559.0 | 26,460.8 |
| Cost of Goods Sold | -- | 6,667.0 | -- |
| Gross Profit | -- | 22,892.0 | -- |
| Gross Profit Margin | 0.0% | 77.4% | 0.0% |
| SG&A Expense | -- | 12,942.0 | -- |
| Depreciation & Amortization | -- | 1,856.0 | -- |
| Operating Income | -- | 8,094.0 | -- |
| Operating Margin | -- | 27.4% | -- |
| Nonoperating Income | -- | 950.0 | -- |
| Nonoperating Expenses | -- | 1,061.0 | -- |
| Income Before Taxes | -- | 7,983.0 | -- |
| Income Taxes | -- | 2,356.0 | -- |
| Net Income After Taxes | 0.0 | 5,627.0 | 0.0 |
| Continuing Operations | -- | 5,627.0 | -- |
| Discontinued Operations | -- | -- | -- |
| Total Operations | -- | 5,627.0 | -- |
| Total Net Income | -- | 5,627.0 | -- |
| Net Profit Margin | -- | 19.0% | -- |
| Diluted EPS from Total Net Income ($) | -- | -- | -- |
| Dividends per Share | -- | 1.75 | -- |
This data is provided as per license from EDGAR Online
